AGA AbstractsSa1052: IMMUNOGENICITY AND SAFETY OF STANDARD AND THIRD DOSE SARS-COV-2 VACCINATION IN PATIENTS WITH IMMUNE-MEDIATED INFLAMMATORY DISEASES; A PROSPECTIVE COHORT STUDY
Cited by (0)
Copyright © 2022 AGA Institute. Published by Elsevier Inc. All rights reserved.